BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2723456)

  • 1. The activity of isoxazolyl penicillins in experimental staphylococcal infection.
    Renneberg J; Forsgren A
    J Infect Dis; 1989 Jun; 159(6):1128-32. PubMed ID: 2723456
    [No Abstract]   [Full Text] [Related]  

  • 2. Amoxycillin-clavulanate versus methicillin or isoxazolyl penicillins for treatment of Staphylococcus aureus infections.
    Moreillon P
    J Antimicrob Chemother; 1995 Mar; 35(3):435-41. PubMed ID: 7782261
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current status of the resistance behavior of staphylococci to isoxazolyl penicillins (oxa-, cloxa-, and dicloxacillin)].
    Matz K; Schassan HH; Faerber CH; Kornmüller KJ
    Zentralbl Bakteriol Orig A; 1974; 228(1):270-2. PubMed ID: 4154678
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of dicloxacillin, oxacillin, and nafcillin upon staphylococcal population and rate of healing of soft-tissue lesions.
    Hartman RE; Carleton J; Lustberg A; Hamburger M
    Antimicrob Agents Chemother (Bethesda); 1966; 6():64-8. PubMed ID: 5985303
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative efficacy of amoxicillin-clavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus endocarditis in rats.
    Cantoni L; Wenger A; Glauser MP; Bille J
    J Infect Dis; 1989 May; 159(5):989-93. PubMed ID: 2708846
    [No Abstract]   [Full Text] [Related]  

  • 6. Activity of oxacillin versus that of vancomycin against oxacillin-susceptible mecA-positive Staphylococcus aureus clinical isolates evaluated by population analyses, time-kill assays, and a murine thigh infection model.
    Labrou M; Michail G; Ntokou E; Pittaras TE; Pournaras S; Tsakris A
    Antimicrob Agents Chemother; 2012 Jun; 56(6):3388-91. PubMed ID: 22430957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dicloxacillin and flucloxacillin twice daily with probenecid in staphylococcal infections. A clinical and pharmakokinetic evaluation.
    Hedström SA; Kahlmeter G
    Scand J Infect Dis; 1980; 12(3):221-5. PubMed ID: 7433922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between penicillinase production and the in-vitro activity of methicillin, oxacillin, cloxacillin, dicloxacillin, flucloxacillin, and cephalothin against strains of Staphylococcus aureus of different phage patterns and penicillinase activity.
    Frimodt-Møller N; Rosdahl VT; Sørensen G; Hartzen SH; Bentzon MW
    J Antimicrob Chemother; 1986 Jul; 18(1):27-33. PubMed ID: 3489704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The isoxazolyl penicillins: oxacillin, cloxacillin, and dicloxacillin.
    Marcy SM; Klein JO
    Med Clin North Am; 1970 Sep; 54(5):1127-43. PubMed ID: 4919148
    [No Abstract]   [Full Text] [Related]  

  • 10. Pyomyositis presenting as acute abdominal pain.
    Beck W; Grose C
    Pediatr Infect Dis; 1984; 3(5):445-8. PubMed ID: 6387644
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative study of the chemotherapeutic action of semisynthetic penicillins in a generalized staph infection in mice].
    Radkevich TP; Rudzit EA
    Antibiotiki; 1974 Nov; 19(11):984-8. PubMed ID: 4218473
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of amoxycillin/clavulanic acid in experimental Staphylococcus aureus endocarditis in the rat.
    Catherall EJ; Irwin R; Mizen LW
    J Antimicrob Chemother; 1991 Jan; 27(1):117-26. PubMed ID: 2050588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo antibacterial activity of dipeptides of penicillins.
    Beskid G; Grunberg E
    Med Exp Int J Exp Med; 1968; 18(4):327-30. PubMed ID: 5757159
    [No Abstract]   [Full Text] [Related]  

  • 14. Does Staphylococcus aureus acquire resistance to methicillin during beta-lactam therapy?
    Morris AJ; Lang SD
    N Z Med J; 1987 Aug; 100(829):504. PubMed ID: 3455524
    [No Abstract]   [Full Text] [Related]  

  • 15. Flucloxacillin treatment of methicillin-'resistant' and sensitive staphylococcal infection.
    Kidson A; Lilly HA; Lowbury EJ
    J Antimicrob Chemother; 1979 Jul; 5(4):359-64. PubMed ID: 489489
    [No Abstract]   [Full Text] [Related]  

  • 16. Flucloxacillin, a new isoxazolyl penicillin, compared with oxacillin, cloxacillin, and dicloxacillin.
    Sutherland R; Croydon EA; Rolinson GN
    Br Med J; 1970 Nov; 4(5733):455-60. PubMed ID: 5481218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Semi-synthetic penicillin and cephalosporins in therapy].
    Demonty J
    Rev Med Liege; 1968 Oct; 23(20):631-7. PubMed ID: 5742515
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fundamental studies on synthetic cephalosporin antibiotics. 2. Therapeutic effects of oral administration on experimental infections in mice and their distribution in the body].
    Nakazawa S; Tsuji A; Watanaba Y; Tsujimoto S
    J Antibiot B; 1967 Aug; 20(4):254-8. PubMed ID: 4866093
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of rifampicin in staphylococcal infections--a review.
    Kapusnik JE; Parenti F; Sande MA
    J Antimicrob Chemother; 1984 Jun; 13 Suppl C():61-6. PubMed ID: 6381463
    [No Abstract]   [Full Text] [Related]  

  • 20. Newer penicillins.
    Martin WJ
    Med Clin North Am; 1967 Sep; 51(5):1107-26. PubMed ID: 4968307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.